CochraneSystematic reviewAug 2019Patients and professionals
Looks at whether azathioprine or mercaptopurine help stop Crohn's coming back after an operation. The evidence is weak: they may be a little better than placebo, may cause more side effects than mesalazine-type drugs, and may be less effective than anti-TNF biologics, but no firm conclusions can be drawn.
CochraneSystematic reviewJul 2016Patients and professionals
Mesalazine-type drugs (aminosalicylates) are widely used for ulcerative colitis, but this review found little evidence that they work for active Crohn's. Low and high doses of mesalazine were not clearly better than placebo. Some trials comparing high-dose mesalazine with budesonide gave mixed results.
The full list of NICE recommendations. It says a standard steroid is usually the first option for a first flare, budesonide or a 5-ASA may be considered for some people who cannot take standard steroids, and liquid feeds may be considered for children worried about growth. It asks for a TPMT check before azathioprine or mercaptopurine, suggests azathioprine with a short course of metronidazole after a complete ileocolonic resection, and says surgery can be considered early when the disease is limited to the end of the small bowel.